[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE3782651D1 - Anwendung von n-(2-(diaethylamino)aethyl)-2-methoxy-4((1-h-4,5-dihydro-2-imidazolyl)amino)-5-chlorobenzamid als anxiolytisches und antipsychotisches mittel. - Google Patents

Anwendung von n-(2-(diaethylamino)aethyl)-2-methoxy-4((1-h-4,5-dihydro-2-imidazolyl)amino)-5-chlorobenzamid als anxiolytisches und antipsychotisches mittel.

Info

Publication number
DE3782651D1
DE3782651D1 DE8787401364T DE3782651T DE3782651D1 DE 3782651 D1 DE3782651 D1 DE 3782651D1 DE 8787401364 T DE8787401364 T DE 8787401364T DE 3782651 T DE3782651 T DE 3782651T DE 3782651 D1 DE3782651 D1 DE 3782651D1
Authority
DE
Germany
Prior art keywords
chlorobenzamide
anxiolytic
dihydro
methoxy
diaethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787401364T
Other languages
English (en)
Other versions
DE3782651T2 (de
Inventor
Jacques Acher
Jean-Claude Monier
Jean-Paul Schmitt
Brenda Costall
Robert Naylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Delagrange SA
Original Assignee
Laboratoires Delagrange SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Delagrange SA filed Critical Laboratoires Delagrange SA
Publication of DE3782651D1 publication Critical patent/DE3782651D1/de
Application granted granted Critical
Publication of DE3782651T2 publication Critical patent/DE3782651T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8787401364T 1987-06-17 1987-06-17 Anwendung von n-(2-(diaethylamino)aethyl)-2-methoxy-4((1-h-4,5-dihydro-2-imidazolyl)amino)-5-chlorobenzamid als anxiolytisches und antipsychotisches mittel. Expired - Fee Related DE3782651T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87401364A EP0295350B1 (de) 1987-06-17 1987-06-17 Anwendung von N-[2-(diäthylamino)äthyl]-2-methoxy-4[(1-H-4,5-dihydro-2-imidazolyl)amino]-5-chlorobenzamid als anxiolytisches und antipsychotisches Mittel

Publications (2)

Publication Number Publication Date
DE3782651D1 true DE3782651D1 (de) 1992-12-17
DE3782651T2 DE3782651T2 (de) 1993-03-25

Family

ID=8198221

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787401364T Expired - Fee Related DE3782651T2 (de) 1987-06-17 1987-06-17 Anwendung von n-(2-(diaethylamino)aethyl)-2-methoxy-4((1-h-4,5-dihydro-2-imidazolyl)amino)-5-chlorobenzamid als anxiolytisches und antipsychotisches mittel.

Country Status (5)

Country Link
US (2) US5116859A (de)
EP (1) EP0295350B1 (de)
JP (1) JPS6485914A (de)
AT (1) ATE82124T1 (de)
DE (1) DE3782651T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
FR2640507A1 (fr) * 1988-12-20 1990-06-22 Delagrange Laboratoires Application de benzamides substitues comme anxiolytiques et anti-psychotiques
FR2645742A1 (fr) * 1989-04-12 1990-10-19 Delagrange Laboratoires Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive
US20040251175A1 (en) * 1998-10-30 2004-12-16 Adams Thomas C. Apparatuses and methods for making glued screen assemblies
CA2664985A1 (en) * 2006-09-29 2008-04-10 The Board Of Trustees Of The University Of Illinois Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
FR2592042B1 (fr) * 1985-12-19 1988-03-25 Ile De France Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
US4887780A (en) * 1988-12-30 1989-12-19 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Orbiter escape pole

Also Published As

Publication number Publication date
EP0295350B1 (de) 1992-11-11
EP0295350A3 (en) 1990-07-04
DE3782651T2 (de) 1993-03-25
US5141949A (en) 1992-08-25
US5116859A (en) 1992-05-26
JPS6485914A (en) 1989-03-30
ATE82124T1 (de) 1992-11-15
EP0295350A2 (de) 1988-12-21

Similar Documents

Publication Publication Date Title
FR2712286B1 (fr) Nouveaux N-mercaptoalkyl alcanediamines et leur utilisation.
ATE81503T1 (de) N-(mercaptoalkyl)-omega-hydroxyalkylamide und ihre verwendung als reduktionsmittel in einem verfahren zur bleibenden gestaltung von haaren.
ATE210637T1 (de) Herstellung und anwendung von ortho-sulfonamido- aryl-hydroxamsäuren als matrix-metalloproteinase- und tace-inhibitoren
ES2123922T3 (es) Utilizacion de un antagonista de substancia p en una composicion cosmetica y composicion obtenida.
PT96405A (pt) Processo para a preparacao de derivados da 3-aminopiperidina e de heterociclos afins contendo azoto
ES2055372T3 (es) Composicion de lavado de las materias queratinicas.
FI913142A (fi) Migraenfoerhindrande alkoxipyrimidinderivat.
ATE116983T1 (de) Indolderivate als antiallergische und antiinflammatorische mittel.
DE69013601D1 (de) Heteroaryl Piperazine als antipsychotische Mittel.
ID945B (id) Turunan-turunan baru kroman dan tiokroman
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
DE3774858D1 (de) Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeuren und deren verwendung als collagenase-inhibitoren.
DE3782651D1 (de) Anwendung von n-(2-(diaethylamino)aethyl)-2-methoxy-4((1-h-4,5-dihydro-2-imidazolyl)amino)-5-chlorobenzamid als anxiolytisches und antipsychotisches mittel.
ATE203021T1 (de) Verwendung von lactamverbindungen als pharmazeutische wirkstoffe
ATE107634T1 (de) L-glutamsäure-derivate.
IS3498A7 (is) Dísúbstitúeruð benzylamín, aðferð til framleiðsluþeirra, notkun þeirra til lækninga og efni til nýmyndunar þeirra
ATE126532T1 (de) Modifizierte protease, verfahren zu deren herstellung und diese enthaltende kosmetische zusammensetzungen.
DE69700871D1 (de) Verwendung von Diimino-isoindolin- oder 3-Amino-isoindolon-Derivaten zum Färben von Keratinfasern und Zusammensetzungen zum färben, die diese enthalten
DE59001142D1 (de) Acetale von oxo-tetralinen und von oxo-indanen.
DE59510713D1 (de) N-substituierte 3-azabicyclo(3.2.0)heptan-derivate als neuroleptika
ATE81455T1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
DK0532629T3 (da) 1-Piperidinyl-alkanoylarylsulfonamid-derivater
DE69230644D1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
ATE39243T1 (de) 4-(n-ethyl,n-2'-hydroxyethyl)-amino-1-(2''hydroxyethyl)-amino-2-nitro-benzol und mittel zur faerbung von haaren.
DE3874047D1 (de) Verwendung von campholennitrilen als riechstoff.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee